Effectiveness and safety of camrelizumab-containing neoadjuvant therapy in patients with esophageal squamous cell carcinoma: a prospective multicenter observational cohort study.

J Thorac Dis · 2023 · PMC10713292 · PMID 38090323

Europe PMC DOI

hedged sentence

0.3000

closest p · 6.0× alpha

0.3000

boldest claim

The sentences

did not reach statistical significanceP=0.30not close (p > 0.1)

23.7%), although this did not reach statistical significance (P=0.30) ( 21 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.